The Practitioner 2010 – 254 (1730): 7

Optimal medical therapy boosts one-year survival rates following acute MI

24 Jun 2010

AUTHORS

Cardiovascular disease
Dr Peter Savill
GPwSI Cardiology, Southampton

Article

One-year mortality following MI can be significantly improved by giving patients a combination of five drug classes: aspirin, beta-blockers, statins, renin angiotensin system (RAS) blockers and thienopyridines. However, less than half of patients receive this optimal therapy, a study from Germany has shown.

All five drug classes have been shown to improve the prognosis in acute MI. The study aimed to provide evidence that combining these drugs reduces mortality in clinical practice.

A total of 5,353 patients with acute MI from the SAMI (Secondary prevention after Acute Myocardial Infarction) registry were studied. The cohort was drawn from 79 German hospitals with a cardiology unit or an internal medicine department.

At hospital discharge 89% of patients were on aspirin, 90% beta-blockers, 84% statins, 81% RAS blockers and 70% a thienopyridine. However, only 46.2% were receiving all drugs i.e. optimal medical therapy.

At one year, 84% of patients were still receiving beta-blockers, 67.5% ACE inhibitors and 11.7% ARBs, 87.7% either clopidogrel or aspirin (89% aspirin, 70% clopidogrel) and 76.8% lipid-lowering agents.

The primary outcome measure was total mortality at one year.

The results showed a reduction in total mortality of 74% in patients receiving optimal medical therapy versus those on one or no drugs, odds ratio 0.26 (95% CI: 0.18 to 0.38, p

The authors found this to be consistent across subgroups defined by STEMI/NSTEMI, diabetes and gender. They also found a reduction in mortality in patients receiving two to four drugs, OR 0.49 (95% CI: 0.35 to 0.68, p

Interestingly, the benefit of optimal therapy was abolished by the withdrawal of beta-blockers, OR 0.63 (95% CI: 0.34 to 1.16) and/or aspirin/clopidogrel, OR 0.59 (95% CI: 0.20 to 1.17).

Improvements in medical, surgical and interventional care have dramatically improved the outcome for patients with acute MI. In the days before modern interventions half of patients would be dead one month after the index event, compared with around 5% today. Optimal medical therapy has a key role to play in this dramatic improvement.

Optimal medical therapy over one year post-infarct was associated with a significantly lower mortality. However, optimal therapy was only being given to less than half of eligible patients.

These findings should further reinforce our efforts to maximise the uptake of these drugs in our post-infarct populations. This should form a key part of cardiac rehabilitation and primary care chronic disease programmes.

 

Dr Peter Savill

REFERENCES

  • Bramlage P, Messer C, Bitterlich N et al. The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart 2010; 96:604-609 doi:10.1136/hrt.2009.188607